micro-community-banner
  • Saved

3yr

Editorial: Phenotypes of myasthenia gravis

Source : https://www.frontiersin.org/articles/10.3389/fneur.2022.1025183/full

(4~34.5) months after disease onset were reported in a study of 86 MG patients. Early-onset MG and precipitating respiratory infection were found as independent risk factors for progression to myasthenic...


Relevance: This special topic, including 13 original research articles, two brief research reports, two reviews, and one opinion article, all relevant to the above-mentioned phenotypic characteristics, contributes to an improved understanding and assessment of MG phenotypes.

  • Saved

3yr
The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study - PubMed

The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36184373/

Pyridostigmine is the most commonly used drug in the symptomatic treatment of myasthenia gravis (MG); however, research into its effectiveness and side effects is scarce. The aim of this study...


Relevance: Pyridostigmine is the most commonly used drug in the symptomatic treatment of myasthenia gravis (MG); however, research into its effectiveness and side effects is scarce. The aim of this study was to assess the effectiveness, prevalence of side effects and net benefit of pyridostigmine.

  • Saved

3yr
Recap of the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Neurologists, physical medicine and rehabilitation physicians, other allied health professionals, and researchers came together for the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) 2022 annual meeting to learn from one another and advance the management and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), muscular dystrophy, Duchenne muscular dystrophy, myasthenia gravis (MG), and spinal muscular atrophy.

The four-day meeting, which included plenary sessions, workshops, and social events, took place at the Gaylord Opryland Resort in Nashville, Tennessee, from Sept. 21 to 24, 2022. Click above for a post-conference wrap-up.

  • Saved

3yr
Recap of the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Neurologists, physical medicine and rehabilitation physicians, other allied health professionals, and researchers came together for the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) 2022 annual meeting to learn from one another and advance the management and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), muscular dystrophy, Duchenne muscular dystrophy, myasthenia gravis (MG), and spinal muscular atrophy.

The four-day meeting, which included plenary sessions, workshops, and social events, took place at the Gaylord Opryland Resort in Nashville, Tennessee, from Sept. 21 to 24, 2022. Click above for a post-conference wrap-up.

 

  • Saved

3yr
Recap of the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Neurologists, physical medicine and rehabilitation physicians, other allied health professionals, and researchers came together for the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) 2022 annual meeting to learn from one another and advance the management and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), muscular dystrophy, Duchenne muscular dystrophy, myasthenia gravis (MG), and spinal muscular atrophy.

The four-day meeting, which included plenary sessions, workshops, and social events, took place at the Gaylord Opryland Resort in Nashville, Tennessee, from Sept. 21 to 24, 2022. Click above for a post-conference wrap-up.